Aster Capital Management DIFC Ltd Has $318,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Aster Capital Management DIFC Ltd boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 1,048.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 3,457 shares of the medical device company’s stock after acquiring an additional 3,156 shares during the period. Aster Capital Management DIFC Ltd’s holdings in Cooper Companies were worth $318,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in COO. Fulton Bank N.A. lifted its position in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock worth $342,000 after purchasing an additional 109 shares during the period. Torray Investment Partners LLC lifted its holdings in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after acquiring an additional 132 shares during the period. Mather Group LLC. boosted its position in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after acquiring an additional 136 shares during the last quarter. Finally, Greenleaf Trust raised its position in Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $73.77 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52 week low of $73.34 and a 52 week high of $112.38. The firm has a market cap of $14.75 billion, a PE ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The firm’s fifty day moving average is $87.76 and its 200-day moving average is $96.14.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Robert W. Baird decreased their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research note on Friday, March 7th. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and issued a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Stifel Nicolaus cut their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.